Turner Healthcare Quality Consulting, Inc.

Delivering value to help you achieve market access and business impact

Turner Healthcare Quality Consulting, Inc.

Delivering value to help you achieve market access and business impact

Experience

THCQ Consulting, Inc. possesses extensive healthcare quality experience that shapes biopharmaceutical strategy in the areas of payer marketing, clinical development, and market access leading to strong business results.

These experiences allows us to engage clients in a manner ensuring 100% alignment with biopharmaceutical compliance and legal policies.

Why THCQ Consulting?

THCQ Consulting, Inc. is uniquely positioned to advise biopharmaceutical clients in the areas of healthcare quality and the external value-based care environment.

We work with clients to deliver quality strategy to optimize market access for medications. This helps get novel therapies to patients who need them most.

We help clients "stand in the shoes" of payer and provider customers to optimize the value delivered in addressing their pain points, with patient needs at the center.

What We Do?

Who We Serve?

THCQ Consulting helps biopharmaceutical clients in the development and implementation of quality strategy to optimize market access for prioritized products.

Find out more

Who We Serve?

Biopharmaceutical firms are our principal clients because this is where THCQ Consulting's industry experience lies, coupled with deep knowledge and experience in healthcare quality and quality measurements.

Find out more

How We Do It?

Who We Serve?

How We Do It?

THCQ Consulting engages with clients to meet them where they are. We offer flexible approaches that match the demands of stated or uncovered healthcare quality and market access challenges.

Find out more

How we helped 3 healthcare brands achieve significant growth

First-of-its-kind Value-based Contract with State Medicaid Program

We garnered leadership buy-in and partnered with market access account managers to establish a risk-sharing agreement between a pharmaceutical firm and a state Medicaid Program for an injectable antipsychotic medication.

Six State Medicaid Market Access Strategy

We leveraged key influence pathways and state Medicaid priorities to achieve strong alignment across a wide range of internal influencers leading to the development of a six-state market access payer strategy for a pharmaceutical client.

Value-Based Clinical Development to Optimize Market Access

We led a pharmaceutical client's commercial market access quality team in optimizing value proposition for a treatment-resistant antidepressant drug candidate through the inclusion of quality measure evidence for a Phase 3 clinical trial.

THCQ Areas of Expertise

Opportunity Identification

Phase 2-3 Clinical Development

Identify customer pain points and opportunities by mapping quality-focused, value-based risk and accountability and the role of products and services on impacting health outcomes and quality of care

Phase 2-3 Clinical Development

Generate data for phase 2-3 clinical development with a focus on quality measures to optimize market access opportunities

Market Access Strategy

Phase 2-3 Clinical Development

Market Access Strategy

Enhance market access by leveraging health care quality policies to evolve payer marketing, market development, and clinical development strategy

Business Insights

Product Value Proposition

Market Access Strategy

Some biopharmaceutical firms lack the internal expertise to position themselves strategically against the dynamics of the external quality and value-based care. We provide strategic advising to raise up an in-house quality strategy function

Service & Advice

Product Value Proposition

We inform internal business strategy and position clients to achieve market access goals by developing payer-specific (i.e., Medicare, Medicaid, commercial) quality and value-based approaches

Product Value Proposition

Use quality-related scientific evidence and brand messaging to reflect external value-based, Quadruple Aim-focused, whole-person-care-centered, health disparity priorities for indicated disease states

Turner Healthcare Quality Consulting, Inc.

Turner Healthcare Quality Consulting, Inc.

Experience

Why THCQ Consulting?

What We Do?

Who We Serve?

Who We Serve?

Who We Serve?

Who We Serve?

Who We Serve?

How We Do It?

Who We Serve?

How We Do It?

How we helped 3 healthcare brands achieve significant growth

First-of-its-kind Value-based Contract with State Medicaid Program

Six State Medicaid Market Access Strategy

Value-Based Clinical Development to Optimize Market Access

President & CEO - Norris G. Turner, PharmD, PhD

nturner@thcqconsulting.com

THCQ Areas of Expertise

Opportunity Identification

Phase 2-3 Clinical Development

Phase 2-3 Clinical Development

Phase 2-3 Clinical Development

Phase 2-3 Clinical Development

Phase 2-3 Clinical Development

Market Access Strategy

Phase 2-3 Clinical Development

Market Access Strategy

Business Insights

Product Value Proposition

Market Access Strategy

Service & Advice

Product Value Proposition

Product Value Proposition

Product Value Proposition

Product Value Proposition

Product Value Proposition

Contact Us

Send us a message!

CHOOSE THCQ CONSULTING

Turner Healthcare Quality Consulting

Cookie Policy